Primary-Care Medication List Accuracy: Clinical Relevance, Challenges, and Strategies for Improvement

Abstract

Ensuring the accuracy of medication lists in primary care is a cornerstone of patient safety and effective chronic disease management. Inaccurate medication documentation can lead to adverse drug events, therapeutic duplications, and compromised clinical decision-making. This review synthesizes recent evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic strategies, management approaches, and guideline recommendations for maintaining accurate medication lists in primary care. Practical implications for clinicians are discussed, along with advances and emerging solutions that leverage health information technology and interprofessional collaboration to reduce medication discrepancies and improve outcomes.

Introduction

Medication list accuracy is a fundamental requirement for safe and effective healthcare delivery, especially in the primary care setting where longitudinal care and care transitions are frequent. Medication discrepancies, including omissions, duplications, dosing errors, and outdated information, pose significant risks for adverse events and suboptimal therapeutic outcomes. Various factors, including polypharmacy, multimorbidity, fragmented care, and limited interoperability of electronic health records (EHRs), complicate efforts to maintain up-to-date and accurate medication lists. Addressing these challenges is essential for advancing patient safety, optimizing pharmacotherapy, and fulfilling regulatory mandates in primary care.

Epidemiology / Disease Burden

Medication discrepancies are highly prevalent in primary care. Studies indicate that up to 50% of medication lists in primary care contain at least one error, with rates even higher among older adults and those with complex regimens. These discrepancies contribute to thousands of preventable adverse drug events annually, resulting in increased hospitalizations, emergency visits, and healthcare costs. The burden is exacerbated by transitions of care, with up to 70% of patients experiencing at least one medication discrepancy upon hospital admission or discharge. The implications are global, affecting healthcare systems with varying resources and EHR capabilities.

Pathophysiology

The pathophysiology of medication list inaccuracy is multifactorial. Errors originate from patient, provider, and system-level factors. Patient-related causes include poor recall, low health literacy, language barriers, and use of over-the-counter or alternative therapies not reported to clinicians. Provider factors encompass incomplete documentation, time constraints, and limited access to comprehensive medication histories. System-level contributors include lack of interoperability between care settings, inadequate medication reconciliation workflows, and variable EHR functionalities. Together, these factors create a complex web of vulnerability, increasing the risk of adverse events through erroneous prescribing or omission of necessary therapy.

Risk Factors

Key risk factors for medication list inaccuracies include polypharmacy (use of five or more medications), advanced age, cognitive impairment, multiple prescribers, frequent transitions of care, and low patient engagement. Patients with chronic diseases, such as diabetes, heart failure, or chronic kidney disease, are at particular risk due to the complexity and frequent adjustment of their medication regimens. Social determinants of health, such as limited access to healthcare and low socioeconomic status, further compound these risks by reducing opportunities for regular medication review and patient education.

Clinical Features

Clinical manifestations of inaccurate medication lists are often indirect but may present as unexplained clinical deterioration, adverse drug events (ADEs), therapeutic failures, or drug interactions. Clinicians may observe inconsistent medication adherence, ineffective symptom control, or unexpected laboratory abnormalities. In some cases, patients may experience overt toxicity, allergic reactions, or hospitalization due to unrecognized duplication or omission of therapy. The consequences underscore the need for vigilance and systematic approaches to medication review in all primary care encounters.

Diagnosis

Diagnosing medication list inaccuracies requires a structured approach. Medication reconciliation—a formal process of comparing the patient’s current medication list against external sources and patient-reported use—is the gold standard. This process involves verification (collecting an accurate history), clarification (ensuring appropriateness and dosing), and reconciliation (documenting and resolving discrepancies). Tools such as the Medication Discrepancy Tool (MDT) and the use of clinical pharmacists in primary care have been shown to improve identification and resolution of medication errors. EHRs with integrated reconciliation modules further aid in identifying discrepancies, though manual review and patient interviews remain indispensable.

Treatment & Management

The primary management strategy is rigorous medication reconciliation at every patient encounter, particularly during transitions of care. Involving patients and caregivers, deploying clinical pharmacists, and utilizing checklists can enhance process reliability. Patient education on medication purpose, dosing, and side effects fosters engagement and accuracy. Interprofessional collaboration—among physicians, nurses, pharmacists, and allied health professionals—improves communication and ensures a shared understanding of the patient’s regimen. Regular audits and feedback on reconciliation practices are also recommended to sustain improvements.

Recent Advances / Emerging Therapies

Recent advances focus on leveraging health information technology and decision support systems. EHR enhancements, such as real-time medication history access from pharmacies, interoperability across care settings, and clinical decision support alerts for potential discrepancies, have demonstrably reduced errors. Mobile health applications and patient portals empower patients to view and update their medication lists, facilitating shared responsibility for accuracy. Artificial intelligence-driven reconciliation tools and natural language processing are emerging to further streamline the process, though real-world validation and clinician acceptance remain areas of active investigation.

Guideline Recommendations

Current guidelines from organizations such as the Joint Commission, Institute for Safe Medication Practices (ISMP), and World Health Organization (WHO) emphasize routine medication reconciliation at all points of care transition. The American Geriatrics Society recommends comprehensive review of all prescribed, over-the-counter, and complementary medications at each visit, especially for older adults and those with polypharmacy. Guidelines highlight the importance of patient involvement, clear documentation, interprofessional teamwork, and leveraging technology to close communication gaps. Adherence to these recommendations is associated with reduced medication errors and improved patient outcomes.

Conclusion

Ensuring medication list accuracy in primary care is a complex but critical challenge with significant implications for patient safety and care quality. Multifaceted strategies encompassing robust reconciliation processes, interprofessional collaboration, patient engagement, and technological innovation are essential to mitigate the risks of medication discrepancies. Adherence to evidence-based guidelines and continued investment in emerging solutions will further strengthen medication safety and optimize therapeutic outcomes in primary care settings.